After a federal appeals court judgment that partially overturned the suspension of a Food and medication Administration approval for a commonly used abortion medication, the Biden administration said it had formally requested the US Supreme Court to get involved. The decision might still stand because the court only partially granted the motion.
US Attorney General Merrick Garland announced that the US Department of Justice would appeal the 5th Circuit Court of Appeals’ decision from Wednesday night, which partially overturned District Judge Matthew Kacsmarky’s decision to halt the FDA’s approval of the abortion drug mifepristone, to the Supreme Court.
Garland clarified that the Department of Justice disputes the 5th Circuit’s ruling rejecting some of their request for a stay pending appeal. In order to safeguard the FDA’s “scientific judgment” and preserve Americans’ access to reproductive healthcare, he said, the government will ask the Supreme Court for immediate relief.
After certain federal judges in Texas and Washington issued inconsistent rulings, the Biden administration made its statement, increasing the likelihood that the matter would ultimately be heard by the Supreme Court.
The abortion medication cannot be sent and can only be used up to the seventh week of the woman’s pregnancy, according to the Wednesday night decision. This decision was made a week after US District Judge Thomas decided that the FDA had to permit the use of mifepristone in 17 Democrat-controlled states nationwide.
The limits are supported by judges Andrew Oldham and Kurt Engelhardt, both of whom were nominated by the Trump administration. Judge Catharine Haynes, who was nominated under the George W. Bush administration, declared that she was vehemently opposed to mifepristone regulation.
The Alliance for Hippocratic Medicine and other pro-life organizations filed lawsuits, which led to the suspension of this chemical abortion medication. Each of these groups was legally represented by attorneys from Alliance Defending Freedom.
